Pixie Dust Technologies Inc Receivables Turnover Ratio (PXDT), from the fourth quarter 2024 to the fourth quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Pixie Dust Technologies Inc   (NASDAQ: PXDT)
 

Pixie Dust Technologies Inc Accounts Receivables Turnover Ratio from the fourth quarter 2024 to the fourth quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Pixie Dust Technologies Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 5.3, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the Pixie Dust Technologies Inc in Apr 30 2024 quarter, has decreased to 69 days, compared to 82 days, in the 0 quarter.

If we take a look into Healthcare sector 518 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Apr 30 2024 from 3230 to 3345.

What is Receivable Turnover Ratio?
What is Pixie Dust Technologies Inc Selling?


What is Receivable Turnover Ratio?





PXDT Receivables Turnover Ratio (Apr 30 2024)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Apr 30 2023)
IV. Quarter
Y / Y Receivable Change 6.29 % 6.29 % -93.85 % 6.29 % 129.46 %
Y / Y Revenue Change 21.63 % - - - -
Receivable Turnover Ratio (TTM) 5.3 4.45 4.53 3.49 3.54
PXDT's Total Ranking # 3345 # 3230 # 0 # 0 # 3143
Accounts Receivable average collection period days 69 82 80 105 103
Seq. Receivable Change 0 % 1627.78 % -94.21 % 6.29 % 0 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 176
Healthcare Sector # 519
Overall Market # 3345

Receivable Turnover Ratio Statistics
High Average Low
3.54 3.13 2.72
(Apr 30 2023)   (Apr 30 2024)






Financial Statements
Pixie Dust Technologies Inc 's Accounts Receivable $ 2 Millions Visit PXDT's Balance sheet
Pixie Dust Technologies Inc 's Sales TTM $ 6 Millions Visit PXDT's Income Statement
Sources of PXDT's Revenues Visit PXDT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PXDT's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PXDT's Growth Rates PXDT's Roa PXDT's Inventory Turnover Ratio PXDT's Dividend Comparisons
PXDT's Profitability Ratios PXDT's Roi PXDT's Asset Turnover Ratio PXDT's Dividend Growth
PXDT's Valuation Ratios PXDT's Roe PXDT's Financial Strength Ratios PXDT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Apr 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Apr 30 2024 Receivable at quarter ending Apr 30 2024
Semler Scientific inc   10.86 $ 65.881  Millions$ 6.064  Millions
Protalix Biotherapeutics inc   10.84 $ 59.654  Millions$ 5.504  Millions
Medinotec Inc   10.83 $ 5.020  Millions$ 0.464  Millions
Onemednet Corporation  10.74 $ 1.088  Millions$ 0.101  Millions
Stablecoin Development Corporation  10.73 $ 13.502  Millions$ 1.258  Millions
National Healthcare Corp  10.68 $ 1,169.157  Millions$ 109.518  Millions
Mannkind Corporation  10.64 $ 224.599  Millions$ 21.106  Millions
Igc Pharma Inc   10.59 $ 1.345  Millions$ 0.127  Millions
Thermogenesis Holdings Inc   10.57 $ 8.561  Millions$ 0.810  Millions
Strata Critical Medical Inc   10.50 $ 231.423  Millions$ 22.030  Millions
Lipella Pharmaceuticals Inc   10.47 $ 0.477  Millions$ 0.046  Millions
Biofrontera Inc   10.29 $ 37.724  Millions$ 3.667  Millions
Option Care Health Inc   10.24 $ 4,431.875  Millions$ 432.691  Millions
Tandem Diabetes Care Inc   10.18 $ 769.825  Millions$ 75.647  Millions
Co diagnostics Inc   10.11 $ 6.678  Millions$ 0.661  Millions
Rockwell Medical inc   10.06 $ 85.392  Millions$ 8.491  Millions
Procyon Corporation  9.95 $ 4.774  Millions$ 0.480  Millions
Quidelortho Corp  9.93 $ 2,862.700  Millions$ 288.225  Millions
Viemed Healthcare Inc   9.86 $ 194.045  Millions$ 19.687  Millions
Addus Homecare Corp  9.75 $ 1,086.454  Millions$ 111.398  Millions
Immucell Corporation  9.64 $ 19.702  Millions$ 2.043  Millions
Clearpoint Neuro Inc   9.56 $ 26.161  Millions$ 2.736  Millions
Radnet Inc   9.53 $ 1,657.773  Millions$ 173.874  Millions
Revance Therapeutics Inc   9.46 $ 236.645  Millions$ 25.005  Millions
Equillium Inc   9.30 $ 37.894  Millions$ 4.074  Millions
Travere Therapeutics Inc   9.29 $ 183.225  Millions$ 19.719  Millions
Myomo Inc   9.26 $ 19.035  Millions$ 2.056  Millions
The Pennant Group Inc   9.24 $ 575.342  Millions$ 62.269  Millions
Scientific Industries Inc   9.22 $ 10.790  Millions$ 1.171  Millions
Eton Pharmaceuticals Inc   9.21 $ 32.764  Millions$ 3.558  Millions

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.